Annex™ Adjacent Level System for Treatment of Adjacent Level Disease
- Conditions
- Degenerative Disc DiseaseAdjacent Level Disease
- Interventions
- Device: Annex™ Adjacent Level System
- Registration Number
- NCT02108249
- Lead Sponsor
- Spine Wave
- Brief Summary
The purpose of this study is to evaluate the clinical, radiological, and surgical outcomes of the Annex™ Adjacent Level System for the treatment of adjacent level disease of the lumbar spine. The Annex™ Adjacent Level System is a spinal fixation system intended to be used with commercially available pedicle screw fixation systems in order to extend existing pedicle screw constructs. Subjects will be evaluated over a 2 year period and compared to historical control.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- Men or women 18-85 years of age
- Single level adjacent level segment disease (ALD) in the lumbar spine (L1-S1).
- trauma, tumor, pseudoarthrosis, revision, or same-level recurrent stenosis
- cervical fusion candidates
- extraspinal cause of back pain
- local or systemic infection
- pregnant / able to become pregnant and not following a reliable contraceptive method
- Severe osteoporosis or osteopenia
- Morbid obesity defined as BMI > 40
- Anatomy or other factors that prohibit safe surgical access to the surgical site
- Allergy or sensitivity to any component of the treatment procedure
- Inadequate tissue coverage over the operative site
- Inadequate bone stock or bone quality
- Fever or leukocytosis
- Uncorrectable coagulopathy or hemorrhagic diathesis
- Cardiopulmonary conditions that present prohibitive anesthesia risk
- Neuromuscular disease or disorder
- Mental illness
- Has an active workman's compensation claim
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Annex Group Annex™ Adjacent Level System Patients prospectively treated with Annex™ Adjacent Level System
- Primary Outcome Measures
Name Time Method Surgical Complication rate compared to retrospective chart review Within 30 days of treatment % Improvement in Operative/Discharge parameters including surgical time and hospital stay within 30 days after treatment
- Secondary Outcome Measures
Name Time Method % Improvement in Quality of Life using SF-36 Up to 2 years post-treatment % Patient Satisfaction with procedure Up to 2 years post-treatment % Improvement in Disability using ODI Up to 2 years post-treatment % Pain reduction on VAS Up to 2 years post-treatment
Trial Locations
- Locations (1)
Carolinas Neurosurgery and Spine
🇺🇸Charlotte, North Carolina, United States